The Anaesthetic Efficacy of Tetracaine and Oxymetazoline Compared With Co‐Phenylcaine in Healthy Individuals
Clinical Otolaryngology · 2025
DOI: 10.1111/coa.14223 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Clinical Otolaryngology, 2025. Verfasst von Samuel J M Hale und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Oxymetazoline, Anesthetics, Local, Tetracaine, Drug Combinations. Die Arbeit nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Garnett Passe and Rodney Williams Memorial Foundation.
Abstract (Originalsprache)
Objectives
Nasal anaesthetic‐decongestant sprays are commonly used prior to nasal instrumentation, such as flexible and rigid nasal endoscopy. Co‐phenylcaine (lignocaine 5%, phenylephrine 0.5%, ENT Technologies Pty Ltd., Melbourne, VIC, Australia) is a combination spray commonly used for this purpose. However, lignocaine is less potent than other local anaesthetics, and both active constituents of Co‐phenylcaine have a bitter taste. It was hypothesised that a combination spray containing tetracaine and oxymetazoline would both offer more potent topical anaesthesia and have a better taste.
Methods
Four anaesthetic‐decongestant nasal sprays were tested in 10 healthy participants ( Co‐phenylcaine , and tetracaine 0.5%, 1% and 2% with oxymetazoline 0.05%). Sensory thresholds were sequentially measured at the head of the inferior turbinate using Semmes‐Weinstein monofilaments over the following hour. Participants also rated taste on a Likert‐style scale, and reported whether they experienced subjective numbness of the maxillary teeth.
Results
A median peak sensory threshold of 60 g (the maximum tested) was observed with Co‐phenylcaine , but this threshold was exceeded by all the tetracaine‐based sprays. Tetracaine 2% with oxymetazoline 0.05% had a significantly more rapid onset than Co‐phenylcaine (4 min vs. 6 min, p < 0.05) and a longer duration of action. Eight participants reported dental numbness after administration of tetracaine 2% with oxymetazoline 0.05%, but only one participant after Co‐phenylcaine. Tetracaine‐based sprays were generally perceived to taste less unpleasant than Co‐phenylcaine.
Conclusion
Tetracaine 2% with oxymetazoline 0.05% is a more potent and rapidly acting anaesthetic‐decongestant spray than Co‐phenylcaine , with a longer duration of action.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Surgery, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
ORCID-Profile: Samuel J M Hale, Richard G Douglas
Förderung
- Garnett Passe and Rodney Williams Memorial Foundation
Zitieren
APA
Hale, S. J. M., Lengyel, O., Louis, D., Kim, R., & Douglas, R. G. (2025). The Anaesthetic Efficacy of Tetracaine and Oxymetazoline Compared With Co‐Phenylcaine in Healthy Individuals. Clinical Otolaryngology. https://doi.org/10.1111/coa.14223
Vancouver
Hale SJM, Lengyel O, Louis D, Kim R, Douglas RG. The Anaesthetic Efficacy of Tetracaine and Oxymetazoline Compared With Co‐Phenylcaine in Healthy Individuals. Clinical Otolaryngology. 2025. doi:10.1111/coa.14223
BibTeX
@article{Hale2025,
author = {Hale, Samuel J M and Lengyel, Olivia and Louis, Deanna and Kim, Raymond and Douglas, Richard G},
title = {The Anaesthetic Efficacy of Tetracaine and Oxymetazoline Compared With Co‐Phenylcaine in Healthy Individuals},
journal = {Clinical Otolaryngology},
year = {2025},
doi = {10.1111/coa.14223}
}
EUVIMED